Y-Intercept (HK)’s AnaptysBio ANAB Stock Holding History

Y-Intercept (HK)’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.25M	Sell	18,468 -4,233	-19%	-$257K	0.02%	947
2026 Q1	$1.26M	Sell	22,701 -10,400	-31%	-$560K	0.02%	928
2025 Q4	$1.6M	Buy	+33,101	New	+$1.29M	0.04%	731
2025 Q1	–	Sell	-23,497	Closed	-$311K	–	1171
2024 Q4	$311K	Buy	+23,497	New	+$569K	0.02%	925
2024 Q3	–	Sell	-20,455	Closed	-$513K	–	1279
2024 Q2	$513K	Buy	+20,455	New	+$476K	0.03%	793

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Y-Intercept (HK)'s ANAB Position: Q2 2026 in Review

Y-Intercept (HK) reduced its AnaptysBio (ANAB) stake by 19% in Q2 2026, selling an estimated $257K and leaving 18,468 shares worth $1.25M. The position accounts for 0.02% of the portfolio, ranked #947.

Y-Intercept (HK) first reported a position in ANAB in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.6M in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Y-Intercept (HK) held 18,468 shares of AnaptysBio worth $1.25M as of Q2 2026.
Y-Intercept (HK) sold 4,233 AnaptysBio shares in Q2 2026, an estimated $257K.
AnaptysBio made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #947 holding.
Y-Intercept (HK) first reported a position in AnaptysBio in Q2 2024 and has held it in 5 quarters since.
Y-Intercept (HK)'s AnaptysBio position peaked at $1.6M in Q4 2025.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.